United States: FDA Takes First Step Toward International Regulation Of Gene Therapies To Treat Rare Diseases - Greenberg Traurig, LLP

United States: FDA Takes First Step Toward International Regulation Of Gene Therapies To Treat Rare Diseases - Greenberg Traurig, LLP

Mondaq

Published

In a groundbreaking development, on Jan. 8, 2024, the U.S. Food and Drug Administration (FDA) announced a pilot program called Collaboration on Gene Therapies Global Pilot (CoGenT Global).

Full Article